| Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells C Wu, B Li, R Lu, SJ Koelle, Y Yang, A Jares, AE Krouse, M Metzger, ... Cell stem cell 14 (4), 486-499, 2014 | 187 | 2014 |
| Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor KH Chen, M Wada, KG Pinz, H Liu, KW Lin, A Jares, AE Firor, X Shuai, ... Leukemia 31 (10), 2151-2160, 2017 | 184 | 2017 |
| Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies KH Chen, M Wada, AE Firor, KG Pinz, A Jares, H Liu, H Salman, ... Oncotarget 7 (35), 56219, 2016 | 110 | 2016 |
| Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells K Pinz, H Liu, M Golightly, A Jares, F Lan, GW Zieve, N Hagag, ... Leukemia 30 (3), 701-707, 2016 | 97 | 2016 |
| Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells KG Pinz, E Yakaboski, A Jares, H Liu, AE Firor, KH Chen, M Wada, ... Oncotarget 8 (68), 112783, 2017 | 89 | 2017 |
| From humble beginnings to success in the clinic: Chimeric antigen receptor-modified T-cells and implications for immunotherapy AE Firor, A Jares, Y Ma Experimental biology and medicine 240 (8), 1087-1098, 2015 | 76 | 2015 |
| Development of an inducible caspase-9 safety switch for pluripotent stem cell–based therapies C Wu, SG Hong, T Winkler, DM Spencer, A Jares, B Ichwan, A Nicolae, ... Molecular Therapy-Methods & Clinical Development 1, 2014 | 69 | 2014 |
| Direct conversion of cord blood CD34+ cells into neural stem cells by OCT4 W Liao, N Huang, J Yu, A Jares, J Yang, G Zieve, C Avila, X Jiang, ... Stem cells translational medicine 4 (7), 755-763, 2015 | 35 | 2015 |
| High Efficiency Restriction Enzyme–Free Linear Amplification-Mediated Polymerase Chain Reaction Approach for Tracking Lentiviral Integration Sites Does Not Abrogate Retrieval Bias C Wu, A Jares, T Winkler, J Xie, JY Metais, CE Dunbar Human gene therapy 24 (1), 38-47, 2013 | 28 | 2013 |
| Stem Cell GeneSALL4in Aggressive Hepatocellular Carcinoma: A Cancer Stem Cell-Specific Target? E Yakaboski, A Jares, Y Ma Hepatology 60 (1), 419-421, 2014 | 24 | 2014 |
| Divergent erythroid megakaryocyte fates in Blvrb-deficient mice establish non-overlapping cytoprotective functions during stress hematopoiesis NM Nesbitt, LE Malone, Z Liu, A Jares, DV Gnatenko, Y Ma, W Zhu, ... Free Radical Biology and Medicine 164, 164-174, 2021 | 10 | 2021 |
| Nuclear localization of SALL4: A stemness transcription factor AE Firor, A Jares Cell Cycle 13 (10), 1522-1523, 2014 | 5 | 2014 |
| Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4 L Wenbin, N Huang, J Yu, A Jares, Y Jianchang, G Zieve, C Avila, X Jiang, ... Stem Cells Translational Medicine 4 (7), 755-763, 2015 | 2 | 2015 |
| Development of an Inducible Caspase-9 Safety Switch for Pluripotent Stem Cell Based Therapies C Wu, SG Hong, A Jares, V Guo, T Winkler, CE Dunbar Blood 120 (21), 2047, 2012 | 1 | 2012 |
| Engineering Stem Cells for Regenerative Medicine A Jares State University of New York at Stony Brook, 2019 | | 2019 |
| Non-Integrative and Small Molecule Strategies for the Generation of Expandable KDR plus Populations from CD34+ Human Umbilical Cord Blood A Jares, H Liu, S Oh, S Patnaik, L Malone, C Avila, AE Firor, K Pinz, Y Ma MOLECULAR THERAPY 26 (5), 83-83, 2018 | | 2018 |
| 647. Efficient Targeting of T Cell Malignancies In Vitro and In Vivo Using CD4-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells KG Pinz, E Yakaboski, A Jares, H Liu, AE Firor, M Wada, LH Leung, ... Molecular Therapy 24, S256-S257, 2016 | | 2016 |
| Quantitative Tracking of the Output of Individual Hematopoietic Stem/Progenitor Cells in a Non-Human Primate Model C Wu, B Li, R Lu, A Jares, R Donahue, I Weissman, C Dunbar MOLECULAR THERAPY 21, S12-S12, 2013 | | 2013 |
| PhD candidate Stony Brook University School of Medicine, New York A Jares | | |
Chuanfeng WuNational Institutes of HealthVerified email at mail.nih.gov
